DGS Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$872K Sell
2,980
-106
-3% -$34.8K 0.14% 137
2025
Q4
$1.08M Buy
3,086
+151
+5% +$51K 0.19% 109
2025
Q3
$948K Sell
2,935
-741
-20% -$230K 0.17% 119
2025
Q2
$1.43M Buy
3,676
+943
+35% +$379K 0.3% 56
2025
Q1
$1.19M Buy
2,733
+1,050
+62% +$422K 0.31% 62
2024
Q4
$621K Sell
1,683
-633
-27% -$265K 0.16% 131
2024
Q3
$1.2M Buy
2,316
+58
+3% +$31K 0.33% 59
2024
Q2
$1.22M Buy
2,258
+84
+4% +$44.4K 0.34% 49
2024
Q1
$1.13M Buy
2,174
+1,022
+89% +$508K 0.32% 53
2023
Q4
$543K Sell
1,152
-119
-9% -$55K 0.21% 90
2023
Q3
$553K Sell
1,271
-25
-2% -$11.3K 0.27% 85
2023
Q2
$576K Sell
1,296
-279
-18% -$129K 0.29% 79
2023
Q1
$724K Sell
1,575
-19
-1% -$9.04K 0.4% 48
2022
Q4
$818K Buy
1,594
+123
+8% +$62.5K 0.53% 38
2022
Q3
$668K Buy
1,471
+84
+6% +$40.2K 0.45% 36
2022
Q2
$669K Buy
1,387
+119
+9% +$58.9K 0.54% 33
2022
Q1
$623K Buy
1,268
+124
+11% +$56.7K 0.38% 42
2021
Q4
$530K Buy
+1,144
New +$481K 0.33% 50

Other funds holding ELV

DGS Capital Management's ELV Position: Q1 2026 in Review

DGS Capital Management reduced its Elevance Health (ELV) stake by 3.4% in Q1 2026, selling an estimated $34.8K and leaving 2,980 shares worth $872K. The position accounts for 0.14% of the portfolio, ranked #137.

DGS Capital Management first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.43M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • DGS Capital Management held 2,980 shares of Elevance Health worth $872K as of Q1 2026.
  • DGS Capital Management sold 106 Elevance Health shares in Q1 2026, an estimated $34.8K.
  • Elevance Health made up 0.14% of DGS Capital Management's portfolio in Q1 2026, its #137 holding.
  • DGS Capital Management first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Elevance Health position peaked at $1.43M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.